Latest Janssen Pharmaceuticals Inc. Stories
New research shows marked differences between Hispanic and non-Hispanic type 2 diabetes patients in disease perceptions and management approaches, highlighting need for tailored education among patients
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
TITUSVILLE, N.J., April 2, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (JPI) today announced it has completed the divestiture of its U.S.
- June re-launch with significantly expanded commercial resources NEWARK, Calif., April 2, 2015 /PRNewswire/ -- Depomed, Inc.
DiabetesSisters is pleased to announce financial support from Janssen Pharmaceuticals Inc.
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
Investigational Anti-thrombin Antibody Ichorcumab Strengthens Cardiovascular Disease Portfolio RARITAN, N.J., March 19, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc.
NEWARK, Calif., March 17, 2015 /PRNewswire/ -- Depomed, Inc.
Trial in Philadelphia involves allegations that Janssen Pharmaceuticals and parent company, Johnson & Johnson, failed to warn about the risks of male breast growth, a condition known as gynecomastia,
Johnson & Johnson's bid for a mistrial in a Risperdal case was dismissed by a Pennsylvania state judge, who ruled that the plaintiffs are allowed to bring a new expert to trial after J&J
- an ornament or knob in the shape of a flower
- In architecture, a floral ornament; specifically, the large conventional flower usually placed in the center of the abacus of a Corinthian capital or classic ceiling-caisson; also, the floreated termination of a Gothic finial.